What's Missing? Discussing Stem Cell Translational Research in Educational Information on Stem Cell “Tourism”

Rachul C. , “‘What Have I Got to Lose?’ An Analysis of Stem Cell Therapy Patients' Blogs,” Health Law Review 20, no. 1 (2011): 5–12; Chen H. and Gottweis H. , “Stem Cell Treatments in China: Rethinking the Patient Role in the Global Bio-Economy,” Bioethics (2011); Ryan K. A. Sanders A. M. Wang D. D. , and Levine A. D. , “Tracking the Rise of Stem Cell Tourism,” Regenerative Medicine 5, no. 1 (2010): 27–33.

Zarzeczny A. and Caulfield T. , “Stem Cell Tourism and Doctors' Duties to Minors,” American Journal of Bioethics 10, no. 5 (2010): 3–15; Zarzeczny A. Rachul C. , and Caulfield T. , “The Phenomenon of Stem Cell Tourism,” in Atala A. , ed., Progenitor and Stem Cell Technologies and Therapies: Principles and Issues, vol. 1 (Cambridge, U.K.: Woodhead Publishing, 2012): At 206–233; Regenberg A. Hutchinson L. Schanker B. , and Mathews D. , “Medicine on the Fringe: Stem Cell-Based Interventions in Advance of Evidence,” Stem Cells 27, no. 9 (2009): 2312–2319; Lindvall O. and Hyun I. , “Medical Innovation Versus Stem Cell Tourism,” Science 324, 5935 (2009): 1664–1665; Sipp D. , “Hope Alone Is Not an Outcome: Why Regulations Make Sense for the Global Stem Cell Industry,” American Journal of Bioethics 10, no. 5 (2010): 33–34; Caplan A. and Levine B. , “Hope, Hype and Help: Ethically Assessing the Growing Market In Stem Cell Therapies,” American Journal of Bioethics 10, no. 5 (2010): 24–25; Foster S. , “The Role of Patients and Patient Advocacy Groups in Educating Patients on the Importance of Legitimate Scientific Research,” American Journal of Bioethics 10, no. 5 (2010): 49.

Song P. , “Biotech Pilgrims and the Transnational Quest for Stem Cell Cures,” Medical Anthropology 29, no. 4 (2010): 384–404.

Sipp D. , “Stem Cell Pseudomedicine: Calling A Spade A Spade,” September 5, 2011, Blog: Stem Cell Treatment Monitor, available at <http://sctmonitor.blogspot.com/2011/09/stem-cell-pseudomedicine-calling-spade.html> (last visited January 16, 2013); Zarzeczny A. Rachul C. Nisbet M. , and Caulfield T. , “Stem Cell Clinics in The News,” Nature Biotechnology 28, no. 12 (2010): 1243–1246; Ryan , supra note 1.

See Lindvall and Hyun , supra note 2.

See Regenberg , supra note 2; Lau D. Ogbogu U. Taylor B. Stafinski T. Menon D. , and Caulfield T. , “Stem Cell Clinics Online: The Direct-to-Consumer Portrayal of Stem Cell Medicine,” Cell Stem Cell 3, no. 6 (2008): 591–594.

See Lau , supra note 6; Regenberg , supra note 2; Ryan , supra note 1.

See Lau , supra note 6; Regenberg , supra note 2; Taylor P. Barker R. Blume K. Cattaneo E. Colman A. , and Deng H. , “Patients Beware: Commercialized Stem Cell Treatments on the Web,” Cell Stem Cell 7, no. 1 (2010): 43–49.

See Lau , supra note 6.

See Zarzeczny , supra note 4.

Amariglio N. Hirshberg A. Scheithauer B.W. Cohen Y. Loewenthal R. , and Trakhtenbrot L. , “Donor-Derived Brain Tumor Following Neural Stem Cell Transplantation in an Ataxia Telangiectasia Patient,” PLoS Medicine 6, no. 2 (2009): E10000029; Miller N. , “Stem Cell Therapy Sees Man “Infected” With Cancer,” November 22, 2009, WAToday, available at <http://www.watoday.com.au/national/stem-cell-therapy-sees-man-infected-with-cancer-20091123-itch.html> (last visited January 17, 2013).

Dobkin B. Curt A. , and Guest J. , “Cellular Transplants in China: Observational Study from the Largest Human Experiment in Chronic Spinal Cord Injury,” Neurorehabilitation and Neural Repair 20, no. 1 (2006): 5–13; Barclay E. , “Stem-Cell Experts Raise Concerns about Medical Tourism,” The Lancet 373, no. 9667 (2009): 883–884.

Thirabanjasak D. Tantiwongse K. , and Thorner P. , “Angiomyeloproliferative Lesions Following Autologous Stem Cell Therapy,” Journal of the American Society of Nephrology 21, no. 7 (2010): 1218–1222.

Vogel G. , “Authorities Shut Controversial German Stem Cell Clinic,” Science Insider, May 10, 2011, available at <http://news.sciencemag.org/scienceinsider/2011/05/authorities-shut-controversial-g.html?rss=1> (last visited January 17, 2013); Mendick R. and Palmer A. , “Baby Death Scandal at Stem Cell Clinic Which Treats Hundreds of British Patients a Year,” October 23, 2010, The Telegraph, available at <http://www.telegraph.co.uk/news/worldnews/europe/germany/8082935/Baby-death-scandal-at-stem-cell-clinic-which-treats-hundreds-of-British-patients-a-year.html> (last visited January 17, 2013); Mendick R. and Hall A. , “Europe's Largest Stem Cell Clinic Shut Down after Death of Baby,” May 8, 2011, The Telegraph, available at <http://www.telegraph.co.uk/news/worldnews/europe/germany/8500233/Europes-largest-stem-cell-clinic-shut-down-after-death-of-baby.html> (last visited January 17, 2013); Cyranoski D. , “Korean Deaths Spark Inquiry,” Nature 468, no. 7323 (2010): 485.

Cyranoksi D. , “Stem-Cell Therapy Faces More Scrutiny In China,” Nature 459, no. 7244 (2009): 146–147; Nature, “Stem-Cell Laws in China Fall Short,” Nature 467, no. 7316 (2010): 633; see Chen and Gottweis , supra note 1.

Stafford N. , “Germany Tightens Law on Stem Cell Treatments,” BMJ 339, (2009): b2967; see Vogel , supra note 14.

See Stafford , supra note 16.

Carrol R. , “Costa Rican Health Ministry Bans Experimental Stem Cell Treatment,” The Guardian, available at <http://www.guardian.co.uk/world/2010/jun/07/costa-rica-stem-cell-treatment> (last visited January 17, 2013).

Than K. , “Hungary Detains 4 over Illegal Stem Cell Treatment,” Reuters, available at <http://www.reuters.com/article/2009/07/29/us-hungary-stemcell-idUSTRE56S4PR20090729?pageNumber=1&virtualBrandChannel=0> (last visited January 17, 2013).

Sung-Sik S. and Gwang-Lip M. , “RNL Bio Probed Over Stem Cell Treatments,” Korea Joongang Daily, available at <http://koreajoongangdaily.joinsmsn.com/news/article/article.aspx?aid=2930548> (last visited January 17, 2013).

Yee J. , “Dominican Authorities Warn Stem Cell Treatments Are Illegal,” BioEdge, available at <http://www.bioedge.org/index.php/bioethics/bioethics_article/9559/> (last visited January 17, 2013); Dominican Today, “Stem Cell Treatments Illegal, Dominican Authorities Warn,” Dominican Today, available at <http://www.dominicantoday.com/dr/local/2011/5/24/39647/stem-cell-treatments-illegal-domincanauthorities-warn> (last visited January 17, 2013).

Cyranoski D. , “China's Stem-Cell Rules Go Unheeded,” Nature 484, no. 7393 (2012): 149–150.

Id.

Ward V. , “Stem Cell Doctor Robert Trossel Struck Off Medical Register,” September 30, 2010, The Telegraph, available at <http://www.telegraph.co.uk/health/healthnews/8033130/Stem-cell-doctor-Robert-Trossel-struck-off-medical-register.html> (last visited January 17, 2013); State of Florida, Department of Health. Final Order No. DOH-11-473-ERO0MGA, File Date February 22, 2011, Case Number: 2010–14317.

Cyranoski D. , “FDA Challenges Stem-Cell Clinic,” Nature 466, no. 7309 (2010): 909; Lysaght T. and Campbell A. , “Regulating Autologous Adult Stem Cells: The FDA Steps Up,” Cell Stem Cell 9, no. 5 (2011): 393–396; von Tigerstrom B. , “The Food and Drug Administration, Regenerative Sciences, and the Regulation of Autologous Stem Cell Therapies,” Food and Drug Law Journal 66 (2011): 479–506; Blevins J. , “Stem-Cell Therapy Feels Food and Drug Administration's Pinch,” April13, 2010, Denver Post, available at <http://www.denverpost.com/news/ci_14871656> (last visited January 17, 2013).

See Federal Bureau of Investigation, San Antonio Division, U.S. Attorney's Office(a), Press Release, Owner of Arizona Company Charged and Convicted of Introducing an Unapproved New Drug – Stem Cells – into Interstate Commerce (August 18, 2011), available at <http://www.fbi.gov/sanantonio/press-releases/2011/owner-of-arizona-company-charged-and-convicted-of-introducing-an-unapproved-new-drug-stem-cells-into-interstate-commerce> (last visited January 17, 2013); See Federal Bureau of Investigation, San Antonio Division, U.S. Attorney's Office(b), Federal Indictments Lead to Arrests in Stem Cell Case, Press Release, December 28, 2011, available at <http://www.fbi.gov/sanantonio/press-releases/2011/federal-indictments-lead-to-arrests-in-stem-cellcase> (last visited January 2, 2012).

Callaway E. , “American Scientist Arrested In Stem-Cell Clinic Sting,” 2011, Nature News blog, available at <http://blogs.nature.com/news/2011/12/american-scientist-arrested-in-stem-cell-clinic-sting.html> (last visited January 17, 2013); Furlow B. , “Arrests in the USA Over Unapproved Stem-Cell Therapies,” The Lancet Oncology 13, no. 2 (2012): 55.

Master Z. and Ogbogu U. , “Stem Cell Tourism in the Era of Personalized Medicine: What We Know, and What We Need to Know,” Current Pharmacogenomics and Personalized Medicine 10, no. 2 (2012): 106–110.

International Society for Stem Cell Research (ISSCR), Patient Handbook on Stem Cell Therapies, December3, 2008, available at <http://www.isscr.org/clinical_trans/pdfs/ISSCRPatientHandbook.pdf> (last visited March 30, 2011).

International Society for Stem Cell Research (ISSCR), “A Closer Look at Stem Cells,” available at <http://www.closer-lookatstemcells.org//AM/Template.cfm?Section=Home1> (last visited April 4, 2012).

Australian Stem Cell Centre, “Stem Cell Therapies: Now and In The Future – The Australian Stem Cell Centre Patient Handbook,” 2009, available at <http://www.msnz.org.nz/Document.Doc?id=23> (last visited January 17, 2013).

UKSCN, UKSCN Position Statement on Stem Cell Tourism, available at <http://www.uknscn.org/downloads/stem_cell_tourism.pdf> (last visited January 17, 2013); Stem Cell Network, “Stem Cell Hype and The Dangers Of Stem Cell ‘Tourism,’” available at <http://www.stemcellnetwork.ca/index.php?page=stem-cell-hype-and-the-dangers-of-stem-cell-tourism> (last visited January 17, 2013).

Parkinson Society Canada, Stem Cell Research and Parkinson's Disease, 2009, available at <http://www.parkinson.ca/atf/cf/%7B9EBD08A9-7886-4B2D-A1C4-A131E7096BF8%7D/stem%20cells%20-%20en.pdf> (last visited January 17, 2013); Australia New Zealand Spinal Cord Injury Network, Stem Cell Interventions for Spinal Cord Injury, 2009, available at <http://www.stemcellcentre.edu.au/site/DefaultSite/filesystem/documents/For%20the%20Public/ANZSCIN%20Stem%20Cell%20Interventions%20for%20Spinal%20Cord%20Injury.pdf> (last visited November 10, 2011); MS Society (U.K.), MS Society Scotland, MS Society Cymru, MS Society Northern Ireland, Stem Cell Therapies in MS, 2010, available at <http://www.mssociety.org.au/documents/Stem-CellBooklet.pdf> (last visited January 17, 2013).

ALSUntangled Group, “ALSUntangled Update 4: Investigating the XCell-Center,” Amyotrophic Lateral Sclerosis 11, no. 3 (2010): 337–338.

See Zarzeczny and Caulfield , supra note 2; Caulfield T. Zarzeczny A. and the Toronto Stem Cell Working Group, “Stem Cell Tourism and Canadian Family Physicians,” Canadian Family Physician 58, no. 4 (2012): 365–368.

Master Z. and Resnik D. B. , “Stem Cell Tourism and Scientific Responsibility,” EMBO Reports 12, no. 10 (2011): 992–995.

See Ryan , supra note 1.

See Rachul , supra note 1; Chen and Gottweis , supra note 1.

See Rachul , supra note 1; Chen and Gottweis , supra note 1; Ryan , supra note 1.

See Rachul , supra note 1.

The quoted passage is from Blog #8 in Rachul , supra note 1, but the quote is not cited in the paper.

The quoted passage is from Blog #12 in Rachul , supra note 1, but the quote is not cited in the paper.

See Chen and Gottweis , supra note 1, at 11.

Kitzinger J. and Williams C. , “Forecasting Science Futures: Legitimising Hope and Calming Fears in the Embryo Stem Cell Debate,” Social Science and Medicine 61, no. 3 (2005): 731–740; Knowles L. P. , Stem Cell Hype and the Dangers Of Stem Cell ‘Tourism,’ 2009, Ethics White Paper for the Stem Cell Network, available at <http://www.stemcellnetwork.ca/uploads/File/whitepapers/Stem-Cell-Hype.pdf> (last visited January 17, 2013); Rachul C. Zarzeczny A. Bublea T. and Caulfield T. , “Stem Cell Research in the News: More Than a Moral Status Debate,” Scripted 7, no. 2 (2010): 311–323; see Ryan , supra note 1.

The cover of this magazine can be found in Time Magazine, How the Coming Revolution in Stem Cells Could Save Your Life, February 9, 2009, available at <http://www.time.com/time/covers/0,16641,20090209,00.html> (last visited January 17, 2013).

The cover of this magazine can be found in The Economist, “Cancer and Stem Cells: The Connection That Could Lead to a Cure,” September 13, 2008, available at <http://www.economist.com/printedition/2008-09-13> (last visited January 17, 2013).

Coghlan A. , “Stem-Cell Find Breathes New Life Into Lung Repair,” October 28, 2011, New Scientist, available at <http://www.newscientist.com/article/dn21102-stemcell-find-breathes-new-life-into-lung-repair.html> (last visited January 17, 2013); Coghlan A. , “Brain Cells Made From Skin Could Treat Parkinson's,” New Scientist, July 6, 2011, available at <http://www.newscientist.com/article/dn20659-brain-cells-made-from-skin-could-treat-parkinsons.html?DCMP=OTC-rss&nsref=online-news> (last visited January 17, 2013); Lyn T. E. , “Stem Cell Team Aims For Spare Heart Parts In Five Years,” August 18, 2011, Reuters, available at <http://www.reuters.com/article/2011/08/18/us-heart-stemcells-idUS-TRE77H0ZM20110818> (last visited January 17, 2013).

See Zarzeczny , supra note 4.

See Chen and Gottweis , supra note 1, at 11.

International Society for Stem Cell Research (ISSCR), Guidelines for the Clinical Translation of Stem Cells, December 3, 2008, available at <http://www.isscr.org/clinical_trans/pdfs/ISSCRGLClinicalTrans.pdf> (last visited March 30, 2011); Rayment E. A. and Williams D. J. , “Concise Review: Mind the Gap: Challenges in Characterizing and Quantifying Cell- and Tissue-Based Therapies for Clinical Translation,” Stem Cells 28, no. 5 (2010): 996–1004.

Knight A. , “Systematic Reviews of Animal Experiments Demonstrate Poor Contribution Towards Human Healthcare,” Reviews on Recent Clinical Trials 3, no. 2 (2008): 89–96.

Sena E. S. van der Worp H. B. Bath P. M. W. Howells D. W. , and Macleod M. R. , “Publication Bias in Reports of Animal Stroke Studies Leads to Major Overstatement of Efficacy,” PLoS Biology 8, no. 3 (2010):e1000344; Weaver J. , “Animal Studies Paint Misleading Picture,” Scientific American, March 30, 2010, available at <http://www.scientificamerican.com/article.cfm?id=animal-studies-paint-misleading> (last visited Apr. 9, 2012).

See Rayment and Williams , supra note 50.

Halme D. and Kessler D. , “FDA Regulation of Stem-Cell– Based Therapies,” New England Journal of Medicine 355, no. 16 (2006): 1730–1735.

Glass K. C. Weijer C. Cournoyer D. Lemmens T. Palmour R. M. , and Shapiro S. H. , “Structuring the Review of Human Genetics Protocols, Part III: Gene Therapy Studies,” IRB 21, no. 2 (1999): 1–9.

Master Z. McLeod M. , and Mendez I. , “Benefits, Risks and Ethical Considerations in Translation of Stem Cell Research to Clinical Applications in Parkinson's Disease,” Journal of Medical Ethics 33, no. 3 (2007): 169–173; Fink D. W. Jr. , “FDA Regulation of Stem Cell-Based Products,” Science 324, no. 5935 (2009): 1162–1163.

Wilson J. , “A History Lesson for Stem Cells,” Science 324, no. 5928 (2009): 727–728.

21 C.F.R. § 312.21; ClinicalTrials.gov, “Understanding Clinical Trials,” available at <http://clinicaltrials.gov/ct2/info/understand> (last visited January 17, 2013); Levine R. , Ethics and Regulation of Clinical Research (New Haven: Yale University Press, 1986): at 6.

21 C.F.R. § 312.21. Id.

See Levine , supra note 58.

Food and Drug Administration, “Tissue and Tissue Product Questions and Answers,” available at <http://www.fda.gov/BiologicsBloodVaccines/TissueTissueProducts/default.htm> (last visited January 17, 2013); 21 C.F.R. § 1270; 21 C.F.R. § 1271.

Health Canada, “Biologics and Genetic Therapies Directorate Centres and Offices,” available at <http://www.hc-sc.gc.ca/ahc-asc/branch-dirgen/hpfb-dgpsa/bgtd-dpbtg/centre-bureau-eng.php> (last visited January 17, 2013).

European Medicines Agency, “Stem Cells,” available at <http://www.ema.europa.eu/ema/index.jsp?curl=pages/special_topics/general/general_content_000471.jsp&mid=WC0b01ac058050f348> (last visited January 17, 2013).

Canadian Institutes of Health Research, “Updated Guidelines for Human Pluripotent Stem Cell Research, June 30, 2010,” available at <http://www.cihr-irsc.gc.ca/e/42071.html> (last visited January 17, 2013).

For example, see von Tigerstrom B. , “The Challenges Of Regulating Stem Cell-Based Products,” Trends in Biotechnology 26, no. 12 (2008): 653–658; Tigerstrom Von , supra note 25.

Wadman M. , “The Bridge between Lab and Clinic,” Nature 468, no. 7326 (2010): 877); Reed J. C. White E. L. Aubé J. Lindsley C. Li M. Sklar L. , and Schreiber S. , “The NIH's Role in Accelerating Translational Sciences,” Nature Biotechnology 30, no. 1 (2012): 16–19.

Pollack A. , “Geron Is Shutting Its Stem Cell Clinical Trial,” New York Times, November 14, 2011, available at <http://www.nytimes.com/2011/11/15/business/geron-is-shutting-down-its-stem-cell-clinical-trial.html> (last visited January 17, 2013).

Prasad V. Cifu A. , and Ioannidis J. P. A. , “Reversals of Established Medical Practices. Evidence to Abandon Ship,” JAMA 307, no. 1 (2012): 37–38.

Kaiser J. , “Embryonic Stem Cells Appear Safe, May Help Eye Disease,” Science Now, January 23, 2012, available at <http://news.sciencemag.org/sciencenow/2012/01/embryonic-stem-cells-appear-safe.html?ref=em&elq=e8ec8290ab0a4cc38cf5c72130ffdcad> (last visited January 17, 2013); Schwartz S. D. Hubschman J. P. Heilwell G. Franco-Cardenas V. , and Pan C. K. , “Embryonic Stem Cell Trials for Macular Degeneration: A Preliminary Report,” The Lancet 379, no. 9817 (2012): 713–720.

Jung H. and Hyun-Young Y. , “South Korea Back in Stem Cell Spotlight with New Treatment,” Reuters, 2011, available at <http://www.reuters.com/article/2011/07/07/us-korea-stemcell-idUSTRE76610C20110707> (last visited January 17, 2013); Reinberg S. , “Stem-Cell Trial Failed to Treat Heart Failure,” HealthDay, March 6, 2012, available at <http://consumer.healthday.com/Article.asp?AID=663058> (last visited January 17, 2013).

Parke S. and Illes J. , “In Delicate Balance: Stem Cells and Spinal Cord Injury Advocacy,” Stem Cell Reviews and Reports 7, no. 3 (2011): 657–663.

See Rachul , supra note 1.

International Society for Stem Cell Research (ISSCR), “Top Ten Things to Know about Stem Cell Treatments,” at Fact #5, available at <http://www.closerlookatstemcells.org/Top_10_Stem_Cell_Treatment_Facts.htm> (last visited January 17, 2013).

See Master , supra note 56.

See International Society for Stem Cell Research (ISSCR), supra note 73 at Fact #6.

International Society for Stem Cell Research (ISSCR), “How Science Becomes Medicine,” available at <http://www.closer-lookatstemcells.org/How_Science_Becomes_Medicine.htm> (last visited October 22, 2011).

Id.; see International Society for Stem Cell Research, supra note 29, at 4.

See International Society for Stem Cell Research, supra note 73.

MS Society (U.K.) et al., supra note 33 at 13; International Society for Stem Cell Research (ISSCR), How Clinical Trials Work, available at <http://www.closerlookatstemcells.org/Clinical_Trials.htm> (last visited October 22, 2011); see International Society for Stem Cell Research, supra note 73; Australian Stem Cell Centre, Stem Cell Therapies: Now and in the Future. The Australian Stem Cell Centre Information Handbook, April 2011, available at <http://www.stemcellcentre.edu.au/For_the_Public/Patient/Handbook.aspx> (last visited April 10, 2012).

See MS Society, supra note 33, at 13.

See Australian Stem Cell Centre, supra note 79.

See International Society for Stem Cell Research, supra note 79; MS Society, supra note 33, at 13; Australian Stem Cell Centre, supra note 79.

See International Society for Stem Cell Research, supra note 79.

See Australian Stem Cell Centre, supra note 79.

See MS Society, supra note 33, at 12.

See Master , supra note 56.

Food and Drug Administration, FDA Seeks Injunction Against Colorado Manufacturer of Cultured Cell Product, FDA News Release, August 6, 2010, available at <http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm221656.htm> (last visited January 17, 2013); Cyranoski , supra note 25; Lysaght and Campbell , supra note 25; Tigerstrom Von , supra note 25; Blevins , supra note 25.

See Lindvall and Hyun , supra note 2.

Id.

Id., at 1664.

See Master and Resnik , supra note 36.

Fox S. and Fallows D. , “Internet Health Resources,” Pew Internet & American Life Project (2003), 1–35, available at <http://papers.ssrn.com/sol3/papers.cfm?abstract_id=2054071> (last visited January 17, 2013).

Baker L. Wagner T. H. Singer S. , and Bundorf M. K. , “Use of the Internet and E-mail for Health Care Information: Results From a National Survey,” JAMA 289, no. 18 (2003): 2400–2406.

Tuffrey C. and Finlay F. , “Use of the Internet by Parents of Paediatric Outpatients,” Archives of Disease in Childhood 87, no. 6 (2002): 534–536; Wainstein B. K. Sterling-Levis K. Baker S. A. Taitz J. , and Brydon M. , “Use of the Internet by Parents of Paediatric Patients,” Journal of Paediatrics and Child Health 42, no. 9 (2006): 528–532.

Diaz J. A. Griffith R. A. Ng J. J. Reinert S. E. , and Friedmann P. D. , “Patients' Use of the Internet for Medical Information,” Journal of General Internal Medicine 17, no. 3 (2002): 180–185.

Hesse B. W. Nelson D. E. Kreps G. L. Croyle R. T. , and Arora N. K. , “Trust and Sources of Health Information,” Archives of Internal Medicine 165, no. 22 (2005): 2618–2624.

Di Pietro N. C. Whiteley L. Mizgalewicz A. , and Illes J. , “Treatment of Neurodevelopmental Disorders: Evidence, Advocacy, and the Internet,” Journal of Autism and Developmental Disorders 43, no. 1 (2012): 122–133.

Schillinger D. Grumbach K. Piette J. Wang F. , and Osmond D. , “Association of Health Literacy with Diabetes Outcomes,” JAMA 288, no. 4 (2002): 475–482; Janson S. L. Fahy J. V. Covington J. K. Paul S. M. , and Gold W. M. , “Effects of Individual Self-Management Education on Clinical, Biological, and Adherence Outcomes in Asthma,” American Journal of Medicine 115, no. 8 (2003): 620–626; Wong A. L. Harker J. O. Lau V. P. Shatzel S. , and Port L. H. , “Spanish Arthritis Empowerment Program: A Dissemination and Effectiveness Study,” Arthritis & Rheumatism 51, no. 3 (2004): 332–336; Nijsten T. Rolstad T. Feldman S.R. , and Stern R. S. , “Members of the National Psoriasis Foundation: More Extensive Disease and Better Informed about Treatment Options,” Archives of Dermatology 141, no. 1 (2005): 19–26; Nielsen D. Ryg J. Nissen N. Nielsen W. , and Knold B. , “Multidisciplinary Patient Education in Groups Increases Knowledge on Osteoporosis: A Randomized Controlled Trial,” Scandinavian Journal of Public Health 36, no. 4 (2008): 346–352; Emtner M. Hedin A. Andersson M. , and Janson C. , “Impact of Patient Characteristics, Education and Knowledge on Emergency Room Visits in Patients with Asthma and COPD: A Descriptive and Correlative Study,” BMC Pulmonary Medicine 9, (2009): 43; Makoul G. Cameron K. A. Baker D. W. Francis L. , and Scholtens D. , “A Multimedia Patient Education Program on Colorectal Cancer Screening Increases Knowledge and Willingness to Consider Screening Among Hispanic/Latino Patients,” Patient Education and Counseling 76, no. 2 (2009): 220–226; Surjadi M. Torruellas C. Ayala C. Yee H. F. Jr. , and Khalili M. , “Formal Patient Education Improves Patient Knowledge of Hepatitis C in Vulnerable Populations,” Digestive Diseases and Sciences 56, no. 1 (2011): 213–219.

Durant J. R. Evans G. A. , and Thomas G. P. , “The Public Understanding of Science,” Nature 340, no. 6228 (1989): 11–14; Evans G. and Durant T. , “The Relationship Between Knowledge and Attitudes in the Public Understanding of Science in Britain,” Public Understanding of Science 4, no. 1 (1995): 57–74; Thomas G. and Durant J. , “Why Should We Promote The Public Understanding Of Science?” Science Literacy Papers 1, (1987): 1–14, available at <http://www.core.org.cn/NR/rdonlyres/Science-Technology-and-Society/STS-014Spring-2006/2737FE74-34D6-4A16-A7DD-95F0FBE60BA0/0/durant_promote.pdf> (last visited May 14, 2011).

Mooney C. , Do Scientists Understand The Public? (Cambridge: American Academy of Arts and Sciences, 2010), available at <http://www.amacad.org/pdfs/scientistsUnderstand.pdf> (last visited January 17, 2013); Nisbet M. C. and Goidel R. K. , “Understanding Citizen Perception of Science Controversy: Bridging the Ethnographic-Survey Research Divide,” Public Understanding of Science 16, no. 4 (2007): 421–440; Priest S. H. , “Misplaced Faith: Communication Variables as Predictors of Encouragement for Biotechnology Development,” Science Communication 23, no. 2 (2001): 97–110; Siegrist M. , “The Influence of Trust and Perceptions of Risks and Benefits on the Acceptance of Gene Technology,” Risk Analysis 20, no. 2 (2000): 195–203; Siegrist M. and Cvetkovich G. , “Perception of Hazards: The Role of Social Trust and Knowledge,” Risk Analysis 20, no. 5 (2000): 713–719; Turney J. , “Public Understanding of Science,” The Lancet 347, no. 9008 (1996): 1087–1090; Ziman J. , “Public Understanding of Science,” Science, Technology, and Human Values 16, no. 1 (1991): 99–105; Priest S. H. Bonfadelli H. , and Rusanen M. , “The ‘Trust Gap’ Hypothesis: Predicting Support for Biotechnology Across National Cultures as a Function of Trust in Actors,” Risk Analysis 23, no. 4 (2003): 751–766; Critchley C. R. , “Public Opinion and Trust in Scientists: The Role of the Research Context, and the Perceived Motivation of Stem Cell Researchers,” Public Understanding of Science 17, no. 3 (2008): 309–327; Liu H. and Priest S. , “Understanding Public Support for Stem Cell Research: Media Communication, Interpersonal Communication and Trust in Key Actors,” Public Understanding of Science 18, no. 6 (2009): 704–718.

Wellcome Trust, “Information And Attitudes: Consulting the Public about Biomedical Science,” 2005, available at <http://www.wellcome.ac.uk/About-us/Publications/Reports/Public-engagement/WTX026430.htm> (last visited January 17, 2013).

See Rachul , supra note 1; Murdoch C. and Scott C. , “Stem Cell Tourism and the Power of Hope,” American Journal of Bioethics 10, no. 5 (2010): 16–23; Kwon B. K. Ghag A. Dvorak M. F. Tetzlaf W. , and Illes J. , “Expectation of Benefit and Tolerance to Risk of Individuals with Spinal Cord Injury Regarding Potential Participation in Clinical Trials,” Journal of Neurotrauma 29, no. 18 (2012): 2727–2737.

Einsiedel E. and Adamson H. , “Stem Cell Tourism and Future Stem Cell Tourists: Policy and Ethical Implications,” Developing World Bioethics 12, no. 1 (2012): 35–44, at 35.

In recognition of these and other potential challenges, we have designed a new public outreach initiative with the support of the Canadian Stem Cell Network. This initiative will produce a patient handbook that will be widely disseminated, including to the organizations included in our study examining online educational information on stem cell tourism, discussed above.

See Caulfield , supra note 35; Levine A. D. and Wolf L. E. , “The Roles and Responsibilities of Physicians in Patients' Decisions about Unproven Stem Cell Therapies,” Journal of Law, Medicine & Ethics 40, no. 1 (2012): 122–134.

Master Z. and Resnik D. B. , “Hype and Public Trust in Science,” Science and Engineering Ethics (2011).

See Master and Resnik , supra note 36.